Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphorylation disorders

Jan A. Smeitink, Massimo Zeviani, Douglass M. Turnbull, Howard T. Jacobs

Research output: Contribution to journalArticle

Abstract

The final steps in the production of adenosine triphosphate (ATP) in mitochondria are executed by a series of multisubunit complexes and electron carriers, which together constitute the oxidative phosphorylation (OXPHOS) system. OXPHOS is under dual genetic control, with communication between the nuclear and mitochondrial genomes essential for optimal assembly and function of the system. We describe the current understanding of the metabolic consequences of pathological OXPHOS defects, based on analyses of patients and of genetically engineered model systems. Understanding the metabolic consequences of OXPHOS disease is of key importance for elucidating pathogenic mechanisms, guiding diagnosis and developing therapies.

Original languageEnglish
Pages (from-to)9-13
Number of pages5
JournalCell Metabolism
Volume3
Issue number1
DOIs
Publication statusPublished - Jan 2006

Fingerprint

Oxidative Phosphorylation
Medicine
Pathology
Mitochondrial Genome
Mitochondria
Adenosine Triphosphate
Communication
Electrons
Therapeutics

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Physiology

Cite this

Mitochondrial medicine : A metabolic perspective on the pathology of oxidative phosphorylation disorders. / Smeitink, Jan A.; Zeviani, Massimo; Turnbull, Douglass M.; Jacobs, Howard T.

In: Cell Metabolism, Vol. 3, No. 1, 01.2006, p. 9-13.

Research output: Contribution to journalArticle

Smeitink, Jan A. ; Zeviani, Massimo ; Turnbull, Douglass M. ; Jacobs, Howard T. / Mitochondrial medicine : A metabolic perspective on the pathology of oxidative phosphorylation disorders. In: Cell Metabolism. 2006 ; Vol. 3, No. 1. pp. 9-13.
@article{fc9a9fa09329463fb02b534acdc87360,
title = "Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphorylation disorders",
abstract = "The final steps in the production of adenosine triphosphate (ATP) in mitochondria are executed by a series of multisubunit complexes and electron carriers, which together constitute the oxidative phosphorylation (OXPHOS) system. OXPHOS is under dual genetic control, with communication between the nuclear and mitochondrial genomes essential for optimal assembly and function of the system. We describe the current understanding of the metabolic consequences of pathological OXPHOS defects, based on analyses of patients and of genetically engineered model systems. Understanding the metabolic consequences of OXPHOS disease is of key importance for elucidating pathogenic mechanisms, guiding diagnosis and developing therapies.",
author = "Smeitink, {Jan A.} and Massimo Zeviani and Turnbull, {Douglass M.} and Jacobs, {Howard T.}",
year = "2006",
month = "1",
doi = "10.1016/j.cmet.2005.12.001",
language = "English",
volume = "3",
pages = "9--13",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Mitochondrial medicine

T2 - A metabolic perspective on the pathology of oxidative phosphorylation disorders

AU - Smeitink, Jan A.

AU - Zeviani, Massimo

AU - Turnbull, Douglass M.

AU - Jacobs, Howard T.

PY - 2006/1

Y1 - 2006/1

N2 - The final steps in the production of adenosine triphosphate (ATP) in mitochondria are executed by a series of multisubunit complexes and electron carriers, which together constitute the oxidative phosphorylation (OXPHOS) system. OXPHOS is under dual genetic control, with communication between the nuclear and mitochondrial genomes essential for optimal assembly and function of the system. We describe the current understanding of the metabolic consequences of pathological OXPHOS defects, based on analyses of patients and of genetically engineered model systems. Understanding the metabolic consequences of OXPHOS disease is of key importance for elucidating pathogenic mechanisms, guiding diagnosis and developing therapies.

AB - The final steps in the production of adenosine triphosphate (ATP) in mitochondria are executed by a series of multisubunit complexes and electron carriers, which together constitute the oxidative phosphorylation (OXPHOS) system. OXPHOS is under dual genetic control, with communication between the nuclear and mitochondrial genomes essential for optimal assembly and function of the system. We describe the current understanding of the metabolic consequences of pathological OXPHOS defects, based on analyses of patients and of genetically engineered model systems. Understanding the metabolic consequences of OXPHOS disease is of key importance for elucidating pathogenic mechanisms, guiding diagnosis and developing therapies.

UR - http://www.scopus.com/inward/record.url?scp=33645052713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645052713&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2005.12.001

DO - 10.1016/j.cmet.2005.12.001

M3 - Article

C2 - 16399500

AN - SCOPUS:33645052713

VL - 3

SP - 9

EP - 13

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 1

ER -